William Patrick Mulloy II - Apr 1, 2022 Form 4 Insider Report for SHARPS COMPLIANCE CORP (SMED)

Role
CEO and President, Director
Signature
Diana Diaz on behalf of the Reporting Person
Stock symbol
SMED
Transactions as of
Apr 1, 2022
Transactions value $
$114,800
Form type
4
Date filed
4/5/2022, 05:58 PM
Previous filing
Apr 4, 2022
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMED Restricted Stock Award Award $0 +20K +105.37% $0.00 39K Apr 1, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMED Sharps Compliance 2010 Stock Plan Options Award $115K +20K $5.74 20K Apr 1, 2022 Common Stock 20K $5.74 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares for the Company's common stock issued under the 2010 Sharps Compliance Stock Plan, as amended, per Mr. Mulloy's Employment Letter Agreement dated April 1, 2022 which includes this Sign-On Restricted Stock Award in connection with Mr. Mulloy's appointment as CEO and President. The restricted shares are subject to the terms and conditions of the underlying Restricted Stock Award Agreement and vest over four (4) years in substantially equal quarterly installments on the last day of each of the Company's fiscal quarters that ends after April 1, 2022.
F2 Amount of securities beneficially owned following the reported transaction includes Common Stock an Restricted Stock Awards
F3 Grant of options to purchase shares of the Company's common stock under the 2010 Sharps Compliance Stock Plan, as amended, per Mr. Mulloy's Employment Letter Agreement dated April 1, 2022 which includes this Sign-On Stock Option Award in connection with Mr. Mulloy's appointment as CEO and President. The options are subject to the terms and conditions of the underlying Stock Option Award Agreement and vest over four (4) years in substantially equal quarterly installments on the last day of each of the Company's fiscal quarters that ends after April 1, 2022.